chikungunya
viru
chikv
member
alphaviru
genu
togavirida
respons
chikungunya
fever
chikf
diseas
character
presenc
incapacit
chikv
transmit
arthropod
vector
aed
aegypti
aed
albopictu
mosquito
latter
implic
transmiss
chikv
indian
ocean
outbreak
past
decad
reemerg
chikv
led
numer
outbreak
differ
part
world
island
indian
outbreak
chikv
infect
also
report
caribbean
chikv
sinc
success
invad
north
central
south
enhanc
arboviru
infect
via
antibodi
first
demonstr
paradox
phenomenon
antibodi
form
complex
bind
virus
interact
cell
surfac
receptor
promot
entri
suscept
host
cell
subsequ
increas
viru
observ
rabi
influenza
dengu
viru
denv
ross
river
viru
rrv
human
immunodefici
viru
hiv
marburg
among
alphavirus
although
viru
enhanc
document
rrv
studi
conduct
use
vitro
murin
cell
linebas
develop
suitabl
infect
system
primari
human
cell
vivo
model
allow
studi
antibodi
enhanc
clinic
import
virus
recent
emerg
zika
viru
zikv
infect
enhanc
crossreact
antidenv
demonstr
antibodymedi
enhanc
chikv
attach
infect
primari
human
monocyt
b
cell
relev
murin
cell
line
presenc
subneutr
level
antichikv
antibodi
obtain
chikvinfect
patient
anim
enhanc
demonstr
mediat
fc
receptor
key
mediat
importantli
two
complementari
anim
model
demonstr
enhanc
chikv
infect
presenc
subneutr
level
antichikv
antibodi
sever
diseas
outcom
increas
lethal
studi
bring
also
caution
import
undesir
effect
antichikv
vaccin
design
investig
subneutr
concentr
chikvspecif
antibodi
enhanc
chikv
infect
dilut
chikvspecif
patient
plasma
obtain
chikv
mix
chikv
use
infect
human
primari
monocyt
b
cell
low
antibodi
concentr
antibodymedi
enhanc
shown
occur
antibodi
concentr
tabl
presenc
chikv
antigen
detect
flow
cytometri
detect
increas
fold
monocyt
fig
fold
b
cell
fig
howev
activ
viru
replic
observ
fig
cell
type
next
zsgreen
tag
chikv
variant
use
infect
human
whole
blood
viru
success
infect
would
lead
product
zsgreen
protein
level
infect
therefor
known
detect
zsgreen
posit
cell
observ
infect
presenc
patient
plasma
total
igg
concentr
led
increas
number
zsgreen
posit
monocyt
howev
observ
b
cell
plasmacytoid
dendrit
cell
pdc
fig
viral
rna
load
concur
enhanc
infect
fig
receptor
depend
pathway
common
mechan
antibodymedi
enhanc
monocyt
express
equal
fig
b
cell
express
fig
investig
play
role
antibodymedi
enhanc
cell
preincub
block
agent
prior
chikv
infect
enhanc
block
significantli
reduc
level
chikv
antigen
detect
monocyt
fig
b
cell
fig
elucid
class
enhanc
chikv
infect
four
differ
stabl
human
b
lymphocyt
cell
line
modifi
stabli
express
singl
class
driven
use
fig
parent
cell
natur
defici
express
use
control
suscept
chikv
infect
fig
signific
increas
chikv
antigen
detect
cell
overexpress
infect
perform
presenc
low
level
chikvspecif
antibodi
fig
cell
overexpress
neither
support
enhanc
chikv
infect
fig
macrophag
hypothes
act
possibl
cellular
vehicl
reservoir
viru
dissemin
use
human
monocytesderiv
macrophag
mdm
express
high
level
ii
fig
antibodymedi
enhanc
chikv
infect
investig
dilut
patient
plasma
total
igg
concentr
experi
infect
perform
zsgreen
tag
chikv
variant
observ
elev
level
zsgreen
posit
cell
detect
hpi
fig
likewis
also
increas
primari
monocyt
isol
donor
fig
despit
increas
level
zsgreen
posit
cell
viral
rna
load
remain
unchang
fig
similarli
enhanc
observ
mediat
via
block
antibodi
complet
abrog
infect
fig
studi
impact
chikv
antibodymedi
enhanc
mice
vitro
chikv
infect
first
perform
mous
macrophag
cell
line
cell
use
sever
studi
investig
effect
antibodymedi
enhanc
infect
close
relat
alphaviru
cell
high
level
fig
result
increas
chikv
infect
observ
hpi
presenc
subneutr
level
chikvspecif
mous
sera
contain
total
igg
antibodi
tabl
fig
increas
chikv
infect
complement
higher
viral
rna
load
fig
given
enhanc
chikv
infect
cell
led
increas
level
chikv
antigen
detect
viral
rna
load
consequ
enhanc
studi
via
gene
express
analys
typei
interferon
ifn
proinflammatori
pathway
fig
expectedli
high
level
sever
proinflammatori
antivir
gene
ino
viperin
detect
start
hpi
chikv
infect
enhanc
fig
establish
evalu
contribut
antibodymedi
enhanc
chikv
infect
vivo
infect
perform
two
differ
wellcharacter
chikv
mous
model
mimic
diseas
use
joint
footpad
week
old
wildtyp
wt
mice
inocul
plaqu
form
unit
pfu
chikv
right
footpad
follow
intraperiton
administr
dilut
chikvspecif
mice
sera
contain
total
igg
concentr
diseas
progress
monitor
daili
viremia
degre
joint
inflamm
footpad
mice
infect
enhanc
condit
significantli
higher
viral
rna
load
acut
phase
diseas
fig
endur
pronounc
inflamm
infect
joint
footpad
fig
tissu
immunephenotyp
fig
reveal
higher
level
infiltr
neutrophil
possibl
cell
joint
footpad
day
postinfect
dpi
enhanc
chikv
infect
fig
moreov
much
lower
number
cell
monocyt
present
poplit
lymph
node
pln
drain
right
footpad
fig
indic
possibl
egress
cell
pln
circul
infect
tissu
enhanc
infect
gene
express
studi
also
reveal
higher
level
well
inflam
footpad
enhanc
infect
coupl
lower
express
fig
second
model
intraderm
chikv
infect
mice
lead
develop
mild
infect
chikv
target
muscl
joint
skin
util
model
week
old
mice
infect
pfu
chikv
via
joint
footpad
assess
outcom
antibodymedi
enhanc
similar
degre
joint
footpad
inflamm
fig
observ
mice
compar
wt
mice
higher
viremia
detect
anim
fig
howev
chikv
infect
perform
presenc
dilut
chikvspecif
mice
sera
concentr
total
igg
increas
viremia
fig
pronounc
joint
footpad
inflamm
fig
observ
mice
observ
reinforc
signific
subneutr
concentr
chikvspecif
antibodi
enhanc
chikv
infect
aggrav
diseas
patholog
demonstr
prophylact
administr
human
purifi
polyval
immunoglobulin
g
igg
contain
antichikv
antibodi
chikvig
protect
suscept
adult
anim
wildtyp
neonat
chikv
assess
antibodi
could
exacerb
chikv
diseas
sever
subneutr
concentr
differ
concentr
chikvig
administ
intraperiton
chikvinfect
day
old
wt
mice
ventral
fig
mortal
observ
mice
receiv
chikvig
concentr
fig
wherea
mice
receiv
either
chikvig
surviv
infect
unexpectedli
approxim
mice
receiv
control
nonchikvspecif
polyval
igg
also
die
infect
fig
nevertheless
viral
rna
load
serum
liver
muscl
determin
chikvinfect
mice
receiv
chikvig
observ
enhanc
chikv
infect
led
signific
viral
burden
muscl
dpi
fig
dpi
fig
taken
togeth
find
highlight
enhanc
chikv
infect
detriment
young
anim
studi
provid
first
document
antibodymedi
enhanc
chikv
infect
vitro
relev
vivo
mous
model
despit
increas
detect
chikv
antigen
primari
human
monocyt
b
cell
mdm
infect
perform
presenc
subneutr
level
chikvspecif
antibodi
viral
replic
increas
antibodymedi
enhanc
viral
infect
report
mostli
involv
involv
enhanc
chikv
infect
may
lead
two
outcom
extrins
intrins
pathway
fig
extrins
pathway
viru
attach
possibl
entri
facilit
without
much
signific
viral
replic
manipul
host
immun
result
obtain
infect
whole
blood
primari
human
monocyt
b
cell
mdm
support
extrins
pathway
play
increas
detect
zsgreen
signal
mdm
later
time
point
suggest
viral
entri
initi
viral
replic
zsgreen
clone
duplic
subgenom
howev
increas
zsgreen
signal
viral
rna
load
may
suggest
enhanc
chikv
infect
necessari
augment
viral
replic
quick
shutdown
viral
replic
may
actual
indic
put
mechan
employ
chikv
chronic
persist
known
chikv
could
persist
chronic
use
macrophag
possibl
cellular
exact
mechan
known
restrict
replic
observ
monocyt
mdm
could
form
immun
subvers
viru
achiev
chronic
hand
intrins
pathway
typic
result
increas
viru
entri
replic
often
accompani
alter
host
immun
fig
intriguingli
enhanc
chikv
infect
murin
macrophag
even
promin
viru
start
replic
hpi
subsequ
led
high
express
sever
proinflammatori
antivir
gene
observ
enthral
similar
studi
denv
rrv
report
downregul
proinflammatori
data
report
differ
open
anoth
compel
perspect
enhanc
chikv
infect
suscept
cell
lead
augment
viru
entri
replic
result
activ
proinflammatori
respons
infect
cell
fig
consequ
elev
immun
respons
remain
investig
plausibl
chikv
manipul
immun
outcom
advantag
achiev
chronic
observ
viral
whether
antibodi
enhanc
neutral
depend
numer
factor
possibl
futur
infect
closelyrel
virus
eg
alphavirus
viru
strain
viru
titer
concentr
epitop
specif
isotyp
affin
patient
plasma
mice
serum
sampl
use
studi
low
dilut
factor
previous
shown
strongli
recogn
epitop
locat
mainli
chikv
furthermor
chikvspecif
antibodi
henc
capabl
move
across
remain
seen
infant
born
mother
infect
chikv
pregnanc
may
suffer
sever
diseas
due
low
level
maternalacquir
chikvspecif
antibodi
report
newborn
mice
infect
denv
presenc
matern
acquir
antidenv
antibodi
sever
diseas
use
joint
footpad
mous
model
chikv
diseas
sever
greatli
enhanc
wt
mice
upon
passiv
administr
low
level
chikvspecif
antibodi
exact
mechan
phenomenon
remain
fulli
elucid
howev
present
studi
disrupt
host
immun
respons
could
crucial
drive
forc
behind
augment
diseas
sever
bring
caution
phenomenon
subneutr
concentr
virusspecif
antibodi
enhanc
sever
infect
advoc
need
care
vaccin
design
extens
preclin
trial
fact
report
chikv
sever
increas
vaccin
mice
present
suboptim
immun
unfortun
also
observ
proport
mice
receiv
human
polyval
antibodi
succumb
chikv
infect
definit
unexpect
observ
could
due
presenc
unknown
artifact
present
control
antibodi
result
outcom
polyval
antibodi
previous
shown
exhibit
immunoreact
conclud
relev
antibodymedi
enhanc
aggrav
viral
diseas
sever
underestim
recent
outbreak
zikv
infect
across
globe
potenti
antidenv
antibodi
crossreact
highlight
relev
anomali
therefor
need
expand
research
effort
understand
prevent
antibodymedi
enhanc
viral
infect
studi
review
approv
institut
review
board
nation
healthcar
group
domain
specif
review
board
dsre
written
inform
consent
obtain
chikf
patient
prior
collect
sampl
human
blood
sampl
obtain
healthi
donor
written
inform
consent
accord
guidelin
health
scienc
author
singapor
studi
approv
number
nu
irb
number
anim
studi
protocol
approv
institut
anim
care
use
committe
iacuc
agenc
scienc
technolog
research
star
iacuc
number
institut
pasteur
anim
ethic
committe
accord
project
use
level
isol
plasma
sampl
patient
admit
acut
chikf
communic
diseas
centr
tan
tock
seng
hospit
cdcttsh
outbreak
august
septemb
use
studi
plasma
previous
studi
plasma
sampl
collect
month
postil
onset
use
patient
plasma
aliquot
store
plasma
sampl
also
collect
healthi
volunt
control
peripher
blood
mononuclear
cell
pbmc
extract
ml
donor
blood
describ
extract
pbmc
subject
either
b
cell
monocyt
isol
use
b
cell
isol
kit
ii
monocyt
isol
kit
ii
miltenyi
biotec
respect
follow
manufactur
instruct
puriti
verifi
flow
cytometri
african
green
monkey
kidney
epitheli
cell
mous
macrophag
cell
line
cell
maintain
dulbecco
modifi
eagl
medium
dmem
gibco
supplement
fetal
bovin
serum
fb
gibco
human
b
lymphocyt
receptor
overexpress
cell
line
cultur
roswel
park
memori
institut
medium
rpmi
supplement
fb
aed
albopictu
monolay
cell
cultur
leibovitz
medium
gibco
supplement
fb
extract
primari
human
cell
maintain
iscov
modifi
dulbecco
medium
imdm
hyclon
supplement
human
serum
hs
idna
biotechnolog
cultur
incub
suppli
except
incub
suppli
media
reagent
test
neg
endotoxin
isol
monocyt
differenti
mdm
modif
briefli
isol
monocyt
allow
differenti
period
day
imdm
hyclon
supplement
hs
idna
biotechnolog
chang
fresh
medium
perform
third
day
nonadh
cell
presum
nondifferenti
monocyt
dead
cell
would
remov
leav
behind
adher
mdm
isol
outbreak
singapor
prepar
cell
use
vitro
experi
involv
isol
primari
human
monocyt
b
cell
cell
whole
blood
mdm
togeth
correspond
precursor
monocyt
fulllength
chikv
infecti
clone
base
chikv
express
zsgreen
protein
use
propag
cell
purifi
use
infect
studi
week
old
mice
infect
studi
day
old
mice
isol
obtain
patient
outbreak
chikv
infect
la
cell
first
stain
human
block
reagent
miltenyi
biotec
stain
follow
antibodi
respect
fluorophor
isotyp
control
follow
manufactur
recommend
fitcconjug
mous
antihuman
ebiosci
apcconjug
mous
antihuman
ebiosci
peconjug
mous
antihuman
ebiosci
mous
isotyp
control
fitc
ebiosci
mous
isotyp
control
apc
ebiosci
mous
isotyp
control
pe
ebiosci
cell
stain
perform
fitcconjug
rat
antimous
antimous
antibodi
r
data
acquir
bd
fac
calibur
bd
bioscienc
use
bd
cellquest
pro
softwar
bd
bioscienc
result
analyz
flowjo
version
softwar
tree
star
chikv
moi
first
incub
dilut
heatinactiv
min
chikvspecif
patient
plasma
anim
sera
serumfre
imdm
hyclon
dmem
gibco
respect
h
shake
heatblock
rpm
use
infect
respect
primari
cell
cell
line
cell
per
infect
h
incub
atmospher
vv
viru
overlay
remov
cell
wash
appropri
serumfre
medium
resuspend
appropri
complet
medium
cell
incub
atmospher
vv
harvest
indic
time
point
harvest
infect
cell
suspens
aliquot
viral
rna
extract
gene
express
studi
aliquot
cell
suspens
spun
result
cell
pellet
dri
store
downstream
total
rna
extract
remain
cell
collect
centrifug
fix
fac
lyse
buffer
bd
bioscienc
store
downstream
stain
procedur
mock
nonenhanc
control
infect
perform
incub
cell
serumfre
dmem
gibco
virus
respect
ex
vivo
infect
human
whole
blood
zsgreen
tag
chikv
variant
pfu
first
incub
dilut
heatinactiv
chikvspecif
patient
plasma
serum
free
imdm
hyclon
h
shake
heatblock
rpm
ad
ml
fresh
citrat
whole
blood
ml
whole
blood
typic
contain
leukocyt
infect
incub
atmospher
vv
harvest
indic
time
point
harvest
mixtur
spun
plasma
obtain
viral
rna
extract
red
blood
cell
subseqeuntli
lyze
cell
pellet
wash
subsequ
fix
fac
lyse
buffer
bd
bioscienc
store
downstream
stain
procedur
mock
nonenhanc
control
infect
perform
incub
cell
serumfre
imdm
hyclon
virus
respect
result
express
fold
enhanc
rel
nonenhanc
infect
fold
enhanc
calcul
accord
equat
fold
enhanc
level
chikv
antigen
detect
enhanc
infect
group
level
chikv
antigen
detect
nonenhanc
infect
group
block
agent
miltenyi
biotec
ad
cell
min
prior
chikv
infect
enhanc
condit
describ
immedi
viru
overlay
remov
cell
wash
harvest
downstream
procedur
mention
block
mous
antihuman
antibodi
stemcel
use
instead
result
express
infect
rel
nontreatedenhanc
infect
reduct
infect
calcul
accord
equat
infect
level
chikv
antigen
detect
treatedenhanc
infect
group
level
chikv
antigen
detect
nontreatedenhanc
infect
group
viral
rna
extract
use
qiaamp
viral
rna
mini
kit
qiagen
follow
manufactur
instruct
viral
rna
load
subsequ
measur
use
real
time
quantit
revers
transcript
pcr
qrtpcr
util
probe
rtpcr
kit
qiagen
modifi
previous
describ
method
detect
negativestrand
fix
cell
permeabil
fac
permeabil
solut
bd
bioscienc
detect
chikv
antigen
primari
human
cell
b
cell
monocyt
stain
done
describ
previous
use
commerci
avail
antialphaviru
mab
santa
cruz
whole
blood
human
mdm
chikv
infect
directli
quantifi
detect
zsgreen
signal
fitc
channel
detect
chikv
antigen
cell
stain
perform
rabbit
antichikv
antibodi
follow
secondari
stain
alexa
fluor
goat
antirabbit
igg
h
l
invitrogen
primari
human
cell
addit
stain
step
perform
surfac
marker
pacificblueconjug
mous
antihuman
mous
antihuman
percp
mous
antihuman
mous
antihuman
antibodi
ebiosci
stain
follow
manufactur
protocol
human
monocyt
b
cell
pdc
defin
specif
surfac
express
respect
data
acquir
use
either
bd
fac
calibur
bd
fac
canto
ii
bd
bioscienc
softwar
use
includ
bd
cellquest
pro
softwar
facscalibur
bd
facsdiva
softwar
facscanto
ii
bd
bioscienc
gate
strategi
shown
fig
total
cell
acquir
result
analyz
flowjo
version
tree
star
total
rna
cell
extract
use
mini
kit
qiagen
accord
manufactur
instruct
without
dnase
treatment
elut
rna
quantifi
dilut
store
gene
express
profil
perform
via
rtpcr
use
quantifasttm
green
rtpcr
kit
qiagen
result
express
rel
fold
chang
express
level
compar
mock
infect
previous
gene
express
data
infect
cell
display
twoway
hierarch
cluster
gener
multi
experi
viewer
version
microarray
softwar
suit
sequenc
primer
use
display
tabl
chikv
infect
week
old
wt
mice
perform
briefli
pfu
chikv
isol
dilut
pb
inocul
subcutan
ventral
side
right
hind
footpad
toward
follow
pb
dilut
chikvspecif
mice
sera
passiv
administ
intraperiton
infect
anim
control
mice
inocul
pb
alon
viremia
degre
footpad
inflamm
monitor
describ
three
week
old
anim
bred
kept
specif
pathogenfre
condit
biolog
resourc
centr
star
biopoli
singapor
vivo
model
human
polyval
immunoglobulin
day
old
femal
mice
inocul
intraderm
ventral
thorax
pfu
chikv
isol
dilut
steril
pb
human
polyval
immunoglobulin
given
intraperiton
follow
viru
inocul
control
anim
given
human
naiv
polyval
antibodi
surviv
experiment
anim
monitor
daili
handl
accord
guidelin
describ
extract
joint
footpad
perform
previous
excis
joint
footpad
shred
digest
digest
medium
contain
dispas
uml
invitrogen
collagenas
iv
mgml
sigmaaldrich
dnase
mix
mgml
roch
appli
scienc
complet
rpmi
medium
h
cell
debri
skin
tissu
remov
pass
cell
strainer
bd
falcon
follow
rbc
lysi
r
system
cell
purifi
spin
vv
percol
sigma
solut
rpmi
prior
stain
poplit
lymph
node
pln
locat
area
back
mice
knee
joint
delic
retriev
briefli
digest
ml
digest
medium
contain
dispas
uml
collagenas
iv
mgml
dnase
mix
mgml
complet
rpmi
medium
min
disintegr
pln
encourag
gentl
pipet
pass
content
nylon
mesh
cloth
sefar
rbc
lyze
rbc
lysi
buffer
r
system
prior
stain
procedur
total
rna
extract
excis
joint
footpad
specimen
first
shred
trizol
invitrogen
micro
smashtm
digit
biolog
microhomogen
system
follow
condit
round
homogen
rpm
follow
ice
subsequ
sampl
spun
remov
unwant
cell
debri
chloroform
ad
trizol
fraction
caus
phase
separ
aqueou
organ
phase
aqueou
phase
contain
rna
care
remov
clean
eppendorf
tube
process
mini
kit
qiagen
accord
manufactur
instruct
use
gene
express
studi
describ
dnase
treatment
perform
total
rna
extract
footpad
pln
cell
resuspend
block
buffer
vv
rat
mous
serum
min
live
cell
stain
livedead
fixabl
aqua
dead
cell
stain
kit
invitrogen
min
stain
follow
cellspecif
marker
follow
manufactur
protocol
rat
anti
mous
bd
bioscienc
rat
antimous
biolegend
pacif
blueconjug
rat
antimous
biolegend
peconjug
rat
antimous
bd
bioscienc
apcconjug
rat
antimous
biolegend
min
room
temperatur
cell
subsequ
wash
fix
neat
ic
fixat
buffer
ebiosci
min
cell
wash
resuspend
flow
cytometri
data
acquisit
data
acquir
bd
facscanto
ii
bd
bioscienc
facsdiva
softwar
analys
perform
use
flowjo
version
tree
star
total
amount
igg
present
heatinactiv
chikvinfect
patient
plasma
chikvinfect
mice
sera
quantifi
igg
human
elisa
kit
igg
mous
elisa
kit
abcam
respect
follow
manufactur
protocol
comparison
differ
group
perform
use
either
nonparametr
mannwhitney
rank
sum
test
parametr
unpair
ttest
two
tail
analys
data
follow
normal
distribut
analyz
perform
graphpad
prism
version
graphpad
softwar
p
valu
consid
statist
signific
